Top 5 obstetric articles of 2019

From screening, to workup and treatment, find out how to provide the best course of action for your pregnant patients with anemia.

In this episode of Pap Talk, Contemporary OB/GYN® sat down with Maneesh Jain, CEO of Mirvie, and Michal Elovitz, MD, chief medical advisor at Mirvie, a new RNA platform that is able to predict pregnancy complications by revealing the biology of each pregnancy. They discussed recently published data regarding the platform's ability to predict preeclampsia and preterm birth.

Despite an increase in mifepristone use to manage early pregnancy loss over time, rates remain low, preventing patients from receiving proven benefits.

Halley Crissman, MD, MPH, and Daphna Stroumsa, MD, MPH, MSC, discuss ways in which ob/gyns can provide high-quality care for transgender and nonbinary people assigned female sex at birth.

In a recent study, similar rates of adverse psychiatric-related outcomes were reported among patients with discontinuation of selective serotonin reuptake inhibitors and serotonin-norepinephrine reuptake inhibitors vs those without discontinuation.

In a recent study, cardiovascular severe maternal morbidity was significantly more common in patients with hypertensive disorders of pregnancy vs those without.